Pneumonia is an infection of pulmonary parenchyma, it is an inflammatory cell in alveolar spaces of lungs by infection, and most commonly is by aspiration from oropharyengeal. It can result from variety of causes including infection with bacteria, viruses' fungi, parasites and chemical and physical injury to lungs. CRP is an acute phase protein levels of which rise in response to inflammation. The present study was undertaken with objectives-to study the hs CRP levels in patient of pneumonia and to study CURB 65 and PSI Score in patient of pneumonia. A cross-sectional study was conducted in department of medicine, Muzaffarnagar Medical College, Muzaffarnagar, having100 patients of pneumonia registered at MMC between 1 st April 2014 to 31 st March 2015. CURB 65 and PSI score were calculated for each patient to stratify into their respective risk class hs CRP LEVELS were measured on day 1 and again on day 5 and 7. High admission hsCRP>70 mg /l were effectively predicts poor out come and severe community acquired pneumonia.
INTRODUCTION:
Pneumonia is an infection of pulmonary parenchyma. It is an inflammation of cells in alveolar spaces of the lungs by infection. It results in proliferation of microbial pathogens at the alveolar level and hosts response to those pathogens [1] . The inflammatory response and disturbance of gas exchange caused by alveolar involvement are responsible for clinical manifestation. Typical symptoms associated with pneumonia include cough, chest pain, fever and difficulty in breathing [2] . Diagnostic tools include xray and examination of sputum and treatment involves use of antibiotics.CPR is an acute phase protein level of which rise in response to inflammation. Its role is to bind the phospocholine receptors expressed on the surface of dead and dying cells and some of bacteria in order to activate complement system. CURB 65 is clinical prediction rule that was validated for predicting mortality in CAP [3] .
MATERIAL AND METHODS:
The study was conducted in the department of Medical Muzaffarnagar Medical College, Muzaffarnagar after being approved by the ethical committee of the institute and after taking informed consent from the patients. A total of 50 patients of pneumonia were enrolled in the study.
Inclusion criteria:
Patient of pneumonia who were -12 year and older of either sex
Exclusion criteria:
Patients with -Acute inflammatory condition other than pneumonia.
-Assicuated chronic medical illness whichmay lead to rise in hsCRP.
-Coronary artery disease -Autoimmune disorders -Chronic kidney disease
METHODS
Hundred patients of pneumonia were enrolled in the study. A detailed history and a though physical examination was done. Investigations including hematology, biochemistry, sputum and blood culture, chest x-ray were done. CURB65 and PSI score were Original Research Article calculated within first 48 hours of admission. HsCRP levels were measured by ELISA method. The repeat hsCRP levels were measured day 5 to 7. The hsCRP levels were correlated with the clinical features, scores and outcome of the patients.
PRINCIPLE OF THE TEST:
The principal of the following enzyme immunoassay test follows a typical two-step capture or 'sandwich' type assay. The assay makes use of two highly specific monoclonal antibodies: A monoclonal antibody specific for CRP is immobilized onto the micro well plate and another monoclonal antibody specific for a different region of CRP is conjugated to horse radish peroxidase (HRP) [4] . CRP from the unknown and calibrators are allowed to bind to the plate, washed, and subsequently incubated with the HRP conjugate.
OBSERVATIONS AND RESULTS:
The study was conducted in 100 patients of pneumonia who presented in medicine emergency, Muzaffarnagar Medical College & Hospital. Detailed history was taken from all the patients and through clinical examination was done Emergency haematological and biochemical investigations along with blood cultures and sputum cultures were sent. Chest x-ray and arterial blood gas analysis was done. CURB65 and PSI scores were calculated for each patient to stratify into their respective risk class. HsCRP levels were measured on day 1 and again between days 5 to 7. Age of the patient ranged from 13 to 85 years. Thirty Six patients out of Hundred were female and Sixty Four were males. Twelve patient out of Hundred, confused at arrival in emergency, whereas remaining Eighty Eight, conscious Vitals of the patients were recorded at their presentation. Pulse of the patient ranged from the minimum of 80 to maximum of 139. Systolic blood pressure ranged from a minimum of 70mm of hg to a maximum of 130. The minimum diastolic blood pressure recorded was 40mm of hg and maximum of 80. Respiratory rate of the patients ranged from minimum of 14 per minute and maximum of 36 per minute. Temperature ranged from minimum of 100 0 F to a maximum of 106 0 F. Haemoglobin of the patients ranged from a minimum of 6.4g% to maximum of 16.5%. The haematocrit of the patients ranged from a minimum of 18 per cent to a maximum of 54. Total leucocyte count of the patients ranged from a minimum of 2420 per dl to maximum of 53400 per dl. The minimum random blood sugar recorded was 64 and the maximum being 260mg/dl. The maximum blood urea recorded was 256 mg/dl and the minimum recorded was 19mg/dl. Serum creatinine concentrations ranged from minimum of .6mg/dl to a maximum of 9 mg/dl. Serum sodium levels recorded was a minimum of 102 meq/L to a maximum of 145meq/L. The minimum ph recorded was 6.86 to maximum of 7.5. The minimum PO 2 recorded was 45.5 and maximum was 97. The minimum hsCRP concentration on day 1 was 65.32 mg/L and maximum was 98.9 mg/L. The minimum hsCRP concentration on day 5-7 was 10.2 mg/L and maximum was 99.90mg/L.
DISCUSSION:
C-reactive protein is an acute phase protein synthesized by the liver in response to tissue damage. Interleukin-6 (IL-6) is thought to be the primary trigger of CRP release, although tumor necrosis factor (TNF)-alpha, IL-1, and other cytokines are thought to be involved. Studies of cytokines and inflammatory markers in community-acquired pneumonia have not translated into clinically useful tests, in part because TNF-alpha and interleukin-6 are detectable in only minority patients [5] . Evidence of a relationship with severity has been conflicting, with some studies who ing that TNF-alpha, IL-6, and soluble interleukin-2 receptor (IL-2R) do not correlate with severity [6] . Others, however, have shown that IL-6 levels correlate with British Thoracic Society severity score and that IL-6 and IL-10 (an anti-inflammatory cytokine) correlate with Apache II score and are higher inpatients fitting the systemic inflammatory response syndrome criteria compared with patients who do not TN alpha, IL-6, and IL-1 beta levels appear also to be higher inpatients admitted to the Intensive Care Unit with pneumonia compared with those with less severe pneumonia [7] . As these cytokines are the primary stimulus for Creactive protein release, it should seem to follow that CRP also should be higher in patients with severe pneumonia [8] . Despite this, there are not studies of larger magnitude examining CRP and mortality in community-acquired pneumonia [9] . However studies have shown that elevated CRP in community-acquired pneumonia in independently associated with requirement for inpatient care, and that higher CRP levels result in longer duration of hospital stay and poorer clinical and radiological recovery [10] . Elevated CRP also has been shown to be associated with increased mortality in lower respiratory tract infection.
CONCLUSIONS AND RECOMMENDATIONS:
High admission hsCRP >70 mg/L effectively predicts poor outcome in severe community-acquired pneumonia and can be used as an adjunct to clinical judgment for identifying high-risk patients who need admission [11] .
1. The time course characteristics of hsCRP, unlike other cytokines, make it ideally suited for use as a peripheral marker in pneumonia. 2. Consecutive C-reactive protein measurements are useful in the first week in follow-up of antibiotic treatment for severe communityacquired pneumonia. 3. A delayed decline in C-reactive protein levels is associated with a higher risk of having received inappropriate antibiotic treatment. 4. In patients admitted to the hospital, a CRP level that falls by 50% or more in 4 days indicates a low risk of 30-day mortality, need for mechanical ventilation and/or inotropic support, or the development of complicated pneumonia. 5. The use of scoring systems offers the clinical and adjective tool when making site-oftreatment decision for patients and when stratifying patients with CAP into risk groups. 6. The CURB-65, with just five variables, in probably the easiest to remember and apply, although it is less accurate at predicting adverse outcomes. CURB-65 seemed superior when quicker decisions were paramount. 7. The addition of co-morbidities into PSI increases its sensitivity to identify patients at risk and deciding site of care. PSI is also an accurate scoring system to predict morbidity in terms of requirement of ICU admission and mechanical ventilation.
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